IPMC 2025 _ Event Postponement
This is to inform that due to some circumstances beyond the organizer control, "3rd Edition of International Precision Medicine Conference" (IPMC 2025) scheduled during March 13-15, 2025 in Rome, Italy has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at precision-medicine@magnusconference.com or call + 1 (702) 988 2320.
3rd Edition of International Precision Medicine Conference
March 13-15, 2025
Companion Diagnostics in Precision Medicine
Companion diagnostic tests identify specific genetic mutations and biomarkers in individuals who are most likely to benefit from precision medicine treatment, lowering the number of patients who are treated. Companion diagnostics play a pivotal role in the development of targeted medications, and their effectiveness determines the success of this type of therapy to a great extent. Companion diagnostic assays use a single patient as a reference point and will be crucial in the transition to more precise and personalized medication. These are medical gadgets that assist doctors in determining the treatments and dosages to offer patients, based on the patient's individual needs. The companion diagnostic is necessary for the drug's safe and effective use.
- FDA approval
- Companion diagnostic genetic test
Alain Chapel
Institute Of Radiological Protection And Nuclear Safety, France
Sergio Marchini
Humanitas Research Hospital, Italy
Michael Thompson
University of Toronto, CanadaSubmit your abstract Today
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model to secure the human healthcare, wellness and biosafety through the view of public health, network-driven healthcare services and lifestyle management
Sergey Suchkov, The Russian University of Medicine & Russian Academy of Natural Sciences, Russian Federation
Title : Potential serum biomarkers for early detection of diabetic nephropathy
Tarek Kamal Motawi , Cairo University, Egypt
Title : Personalized & Precision Medicine (PPM) as a Unique Avenue to have the Healthcare Model Renewed to Secure the National Biosafety: Through The View of Obesity Nutrition to Reach the Personalized Diet Harmony and Lifestyle Wellness
Sergey Suchkov, The Russian University of Medicine & Russian Academy of Natural Sciences, Russian Federation
Title : Personalized and Precision Medicine (PPM) thought The View of Reproductive Healthcare and Natural Family Planning: An Option for clinicians and caregivers realize the potential of genomics-informed care to secure the Individualized Human Biosafety
Sergey Suchkov, The Russian University of Medicine & Russian Academy of Natural Sciences, Russian Federation
Title : 3D Bioprinting complicated large organs with a vascular system
Vyacheslav R Shulunov, Russian Academy of Science, Russian Federation
Title : Persian medicine, medicine based on temperament
Mehdi Zarvandi, Golestan University of Medical Sciences, Iran (Islamic Republic of)